FDA Approves Risankizumab-rzaa for PsA
Pregnancy Outcomes in Patients with Psoriatic Arthritis
New Data Highlight Effectiveness of Guselkumab for Patients with PsA
FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA
Risk of IBD in Patients with Psoriasis, PsA & Ankylosing Spondylitis Starting IL-17 Inhibitors
Risankizumab Effective Against Refractory Psoriatic Arthritis
The Big Picture: How to Assess Disease Activity in Patients with axSpA & PsA in Clinical Practice
Oral CBD Fails to Relieve Pain from Hand OA & PsA